Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

L 693989

Known as: L-693,989, L-Proline, N2-(10,12-dimethyl-1-oxotetradecyl)-(4R,5R)-4,5-dihydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(4-(phosphonooxy)phenyl)-L-threonyl-threo-3-hydroxy-L-glutaminyl-3-hydroxy-, cyclic (6-1)-peptide, monosodium salt, 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Clinical Pharmacokinetics of Inhaled Antimicrobials
AbstractAdministration of inhaled antimicrobials affords the ability to achieve targeted drug delivery into the respiratory tract… Expand
  • figure 1
  • figure 2
  • table 3
1995
1995
Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis
The pneumocandins are semisynthetic analogs of echinocandin-like compounds that have shown efficacy in animal models of systemic… Expand
1994
1994
Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats
Water-soluble pneumocandin L-693,989, a potent antipneumocystis agent in the rat model for Pneumocystis carinii pneumonia (PCP… Expand
Highly Cited
1994
Highly Cited
1994
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase
The lipopeptide antifungal agents, echinocandins, papulacandins, and pneumocandins, kill Candida albicans by inhibiting glucan… Expand
1992
1992
Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats
Water-soluble lipopeptide L-693,989 was evaluated for its antipneumocystis activity in rats. Rats from colonies with latent… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE